Udg Healthcare PLC (LON:UDG) Stock Rating Reaffirmed by Stifel Nicolaus
Stifel Nicolaus reaffirmed their hold rating on shares of Udg Healthcare PLC (LON:UDG) in a research note issued to investors on Thursday. The brokerage currently has a GBX 775 ($10.22) price target on the stock.
A number of other analysts have also issued reports on the company. Liberum Capital reiterated a buy rating and set a GBX 760 ($10.03) price objective on shares of Udg Healthcare PLC in a research note on Tuesday, April 11th. Berenberg Bank boosted their price objective on Udg Healthcare PLC from GBX 745 ($9.83) to GBX 800 ($10.55) and gave the company a hold rating in a research note on Friday, June 23rd. Peel Hunt boosted their price objective on Udg Healthcare PLC from GBX 730 ($9.63) to GBX 830 ($10.95) and gave the company an add rating in a research note on Tuesday, May 23rd. Jefferies Group LLC lowered Udg Healthcare PLC to a hold rating and boosted their price objective for the company from GBX 760 ($10.03) to GBX 785 ($10.35) in a research note on Wednesday, May 24th. Finally, Numis Securities Ltd reiterated a hold rating and set a GBX 730 ($9.63) price objective on shares of Udg Healthcare PLC in a research note on Tuesday, May 23rd. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Udg Healthcare PLC presently has an average rating of Hold and a consensus target price of GBX 799.43 ($10.55).
Udg Healthcare PLC (LON UDG) traded up 1.40% during mid-day trading on Thursday, hitting GBX 831.50. The stock had a trading volume of 471,316 shares. Udg Healthcare PLC has a 52 week low of GBX 567.00 and a 52 week high of GBX 886.50. The company’s 50 day moving average is GBX 847.66 and its 200-day moving average is GBX 751.72. The stock’s market capitalization is GBX 2.06 billion.
TRADEMARK VIOLATION WARNING: This news story was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/05/udg-healthcare-plc-lonudg-stock-rating-reaffirmed-by-stifel-nicolaus.html.
In other news, insider Chris Corbin sold 5,650 shares of the company’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of GBX 827 ($10.91), for a total value of £46,725.50 ($61,635.01). Also, insider Jez Moulding acquired 18,000 shares of the business’s stock in a transaction dated Wednesday, May 31st. The stock was purchased at an average price of GBX 808 ($10.66) per share, with a total value of £145,440 ($191,848.04).
Udg Healthcare PLC Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.